A detailed history of U.S. Capital Wealth Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, U.S. Capital Wealth Advisors, LLC holds 8,620 shares of LLY stock, worth $6.8 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
8,620
Previous 7,989 7.9%
Holding current value
$6.8 Million
Previous $7.23 Million 5.57%
% of portfolio
0.29%
Previous 0.29%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$772.14 - $960.02 $487,220 - $605,772
631 Added 7.9%
8,620 $7.64 Million
Q2 2024

Jul 11, 2024

BUY
$724.87 - $909.04 $82,635 - $103,630
114 Added 1.45%
7,989 $7.23 Million
Q1 2024

May 10, 2024

BUY
$592.2 - $792.28 $491,526 - $657,592
830 Added 11.78%
7,875 $6.13 Million
Q4 2023

Feb 06, 2024

SELL
$525.19 - $619.13 $275,724 - $325,043
-525 Reduced 6.94%
7,045 $4.11 Million
Q3 2023

Oct 19, 2023

SELL
$434.7 - $599.3 $91,287 - $125,852
-210 Reduced 2.7%
7,570 $4.07 Million
Q2 2023

Aug 04, 2023

BUY
$350.74 - $468.98 $250,077 - $334,382
713 Added 10.09%
7,780 $3.65 Million
Q1 2023

May 11, 2023

BUY
$310.63 - $364.82 $45,351 - $53,263
146 Added 2.11%
7,067 $2.43 Million
Q4 2022

Feb 03, 2023

BUY
$321.55 - $374.67 $285,214 - $332,332
887 Added 14.7%
6,921 $2.53 Million
Q3 2022

Nov 01, 2022

SELL
$296.48 - $337.87 $27,276 - $31,084
-92 Reduced 1.5%
6,034 $1.95 Million
Q2 2022

Aug 12, 2022

BUY
$278.73 - $327.27 $92,259 - $108,326
331 Added 5.71%
6,126 $1.99 Million
Q1 2022

May 12, 2022

BUY
$234.69 - $291.66 $13,142 - $16,332
56 Added 0.98%
5,795 $1.66 Million
Q4 2021

Jan 21, 2022

BUY
$224.85 - $279.04 $13,491 - $16,742
60 Added 1.06%
5,739 $1.59 Million
Q3 2021

Nov 01, 2021

BUY
$221.6 - $272.71 $1.26 Million - $1.55 Million
5,679 New
5,679 $1.31 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $750B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track U.S. Capital Wealth Advisors, LLC Portfolio

Follow U.S. Capital Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of U.S. Capital Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on U.S. Capital Wealth Advisors, LLC with notifications on news.